MedPath

FGM in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Phase 1
Conditions
Patients who will receive hematopoietic stem cell transplantation
Registration Number
JPRN-jRCTs052180059
Lead Sponsor
MINAMI Hironobu
Brief Summary

Our study suggests that FreeStyle Libre Pro can be used safely in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). However, glucose levels in tissue interstitial fluid are often lower than those in blood glucose. Therefore, we should pay attention for interpreting glucose levels in tissue interstitial fluid obtained by FreeStyle Libre Pro in HSCT patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
8
Inclusion Criteria

(1)Patients who are at least 20 and under 70 years of age
(2)Patients who will undergo allogeneic hematopoietic stem cell transplantation
(3)Patients who sign a written informed consent
(4)Patients who have never used FreeStyle LibrePro

Exclusion Criteria

(1)Patients who will undergo HLA haplo-identical stem cell transplantation
(2)Patients who need to perform X-ray or CT scan more than once a week
(3)Patients who have infection on their upper arms for sensor sites
(4)Patients who contact dermatitis
(5)Patients who cannot use alcohol and chlorhexidine gluconate for sterilization
(6)Patients who have implanted medical devices
(7)Patients judged inappropriate perticipants for this study by their attending doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath